HomeAOLS • OTCMKTS
add
Aeolus Pharmaceuticals Inc
Previous close
$0.00010
Market cap
15.21K USD
Avg Volume
7.01K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
BNN Bloomberg
1 day ago
Central bank commentary weighs on risk assets, following BoC and Fed rate cuts
0.11%
Financials
Income Statement
Revenue
Net income
| (USD) | 2016info | Y/Y change |
|---|---|---|
Revenue | 2.08M | -33.27% |
Operating expense | 2.47M | 10.77% |
Net income | -3.56M | -35.39% |
Net profit margin | -171.39 | -102.90% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2016info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.16M | 3,256.38% |
Total assets | 4.17M | 134.50% |
Total liabilities | 972.00K | -62.93% |
Total equity | 3.20M | — |
Shares outstanding | 152.09M | — |
Price to book | 0.00 | — |
Return on assets | -68.83% | — |
Return on capital | -122.05% | — |
Cash Flow
Net change in cash
| (USD) | 2016info | Y/Y change |
|---|---|---|
Net income | -3.56M | -35.39% |
Cash from operations | -3.11M | -27.26% |
Cash from investing | — | — |
Cash from financing | 6.17M | 504.90% |
Net change in cash | 3.06M | 315.11% |
Free cash flow | -1.77M | -21.60% |
About
Founded
1994
Headquarters
Website
Employees
4
